NCT05802277UnknownNot Applicable
Characterization of the Mechanical Properties of the Hamstring Muscle Group in Female Athletes: Impact of the Menstrual Cycle and Adaptations to Exercise.
EZUS-LYON 12 sites in 1 country130 target enrollmentStarted: October 5, 2022Last updated:
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 130
- Locations
- 2
- Primary Endpoint
- Hamstring muscles shear wave speed
Study Overview
Brief Summary
The goal of this clinical trial is to precise the impact of menstrual cycle and physical activity on the hamstrings muscle function in healthy active women. The main question it aims to answer is : is there a moment of the menstrual cycle when the muscle is better able to recover from a strenuous exercise ? Three appointments will be conducted to evaluate the hamstring muscles at difference moments of the menstrual cycle. Echographic and maximal force production measures will be done.
Researchers will compare these results with a group taking oral contraceptives.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 35 Years (Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Subject aged between 18 and 35 years.
- •Subjects who practice at least 2 hours of sport per week with a competitive aim.
- •Subject who has not presented any musculo-tendinous pathology to the hamstrings in the last 6 months.
- •Subject with no musculoarticular pathology having a prolonged (more than 2 weeks) interruption of sports activities in the last 2 years.
- •Subject with no muscular pain or pathology currently.
- •Subject with no known cardiac disorders or family history that could present a risk known family history that could present a risk in case of intense physical effort.
- •physical exertion.
- •Subjects not taking any medication, which in the opinion of the that, in the opinion of the coordinating investigator, may interfere with the evaluation of the study criteria.
- •Subject able and willing to comply with the protocol and agreeing to give written informed consent.
- •Subject affiliated or benefiting from a Social Security plan.
- •Menstrual cycle group:
- •Subject whose last 3 menstrual cycles are of a regular duration (± 4 days maximum difference between 2 consecutive menstrual cycles).
- •Subject whose last 3 menstrual cycles are of a duration between 24 and 32 days (including milestones).
- •Absence of any contraceptive method likely to modulate the hormonal variations linked to the menstrual cycle.
- •hormonal variations related to the menstrual cycle, during the duration of the duration of the protocol and during the last 6 months after the participant's inclusion.
- •the participant. Mechanical contraception such as the diaphragm is permitted.
- •Oral contraceptive group:
- •- Taking oral contraception, 2nd generation monophasic pill estrogen-progestin pill (Optilova®, Optidril®, Leeloo®, Minidril®, Ludeal®, Zikiale®, Lovavulo®, Lovapharm®) for at least 6 months.
Exclusion Criteria
- •Subjects with a medical contraindication to intense physical activity.
- •Subject with a positive pregnancy test result.
- •Subject with a medical or surgical history deemed by the coordinating investigator as being incompatible with the study.
- •Subjects under guardianship.
- •Subjects in a period of exclusion from another study.
- •Decision of the volunteer, whatever the reason.
- •Adverse event or effect affecting the safety of the volunteer in the opinion of the coordinating investigator.
- •Major deviation from the protocol.
- •Illness or injury interfering with the normal course of the protocol.
Arms & Interventions
Menstrual cycle group
Experimental
Women who are not currently taking any form of hormonal contraception and who present a regular menstrual cycle.
Intervention: Hamstring muscles function assessment (Diagnostic Test)
Oral contraceptive group
Active Comparator
Women taking a second-generation oral contraceptive estrogen-progestogen pill.
Intervention: Hamstring muscles function assessment (Diagnostic Test)
Outcomes
Primary Outcomes
Hamstring muscles shear wave speed
Time Frame: Length of a menstrual cycle (around on 28 day average)
Differences according to menstrual cycle phase in hamstring muscles shear wave speed, as measured by ultrasound elastography
Secondary Outcomes
- Maximal voluntary force production(Length of a menstrual cycle (around on 28 day average))
- Maximal knee joint range of motion(Length of a menstrual cycle (around on 28 day average))
- Hamstring muscles thickness(Length of a menstrual cycle (around on 28 day average))
- Hamstring muscles length of fascicles(Length of a menstrual cycle (around on 28 day average))
- Hamstring muscles cross sectional area(Length of a menstrual cycle (around on 28 day average))
- Hamstring muscles pennation angle(Length of a menstrual cycle (around on 28 day average))
- Hamstring tendons length(Length of a menstrual cycle (around on 28 day average))
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Unknown
Not Applicable
Biomechanical Changes During Menstrual CycleMenstrual CyclePassive StretchingHamstring MusclesNCT03979326Medical University of Silesia500
Recruiting
Not Applicable
Impact of Menstrual Cycle-Based Resistance Training on Neuromuscular Performance in Female AthletesMenstrual CycleResistance TrainingNeuromuscular FunctionFemale AthleteWomen HealthOral Contraceptive PillMuscle StrenghtHormonesPeriodized TrainingNCT06679491Universite de La Reunion60
Completed
Not Applicable
Performance During Menstrual CyclePerformanceNCT03832972University of Aarhus40
Completed
Not Applicable
Physical Performance of Women at Different Stages of the Menstrual Cycle, and Photobiomodulation TherapyMenstrual Cycle DisorderNCT04281446University of Sao Paulo27
Completed
Not Applicable
The Effect of Exercise on Menstrual SymptomsMenstrual ProblemNCT06006507Uskudar University54